US Patent 11408889 Anti-GITR antibodies for cancer diagnostics
Patent 11408889 was granted and assigned to Bristol-Myers Squibb on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11408889 Anti-GITR antibodies for cancer diagnostics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
